Ibex Wealth Advisors P Lx Pharma Inc. Transaction History

Ibex Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 22, 2022	SELL	$7.69 - $19.66 $2,114 - $5,406	-275 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$12.22 - $21.28 $3,360 - $5,852	275 New	275 $5,000
Q3 2019 Nov 12, 2019	SELL	$4.89 - $7.18 $3,789 - $5,564	-775 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$4.93 - $7.2 $3,820 - $5,580	775 New	775 $5,000

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Ibex Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Ibex Wealth Advisors with notifications on news.